- Home
- PSTV vs PRPH Comparison
PSTV vs PRPH Comparison
Compare PSTV & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTV
- PRPH
- Stock Information
- Founded
- PSTV 1996
- PRPH 1989
- Country
- PSTV United States
- PRPH United States
- Employees
- PSTV N/A
- PRPH N/A
- Industry
- PSTV Medical/Dental Instruments
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- PSTV Health Care
- PRPH Health Care
- Exchange
- PSTV Nasdaq
- PRPH Nasdaq
- Market Cap
- PSTV 17.0M
- PRPH 14.5M
- IPO Year
- PSTV N/A
- PRPH 1997
- Fundamental
- Price
- PSTV $0.41
- PRPH $0.43
- Analyst Decision
- PSTV Strong Buy
- PRPH
- Analyst Count
- PSTV 4
- PRPH 0
- Target Price
- PSTV $7.88
- PRPH N/A
- AVG Volume (30 Days)
- PSTV 6.5M
- PRPH 2.7M
- Earning Date
- PSTV 11-13-2025
- PRPH 11-12-2025
- Dividend Yield
- PSTV N/A
- PRPH N/A
- EPS Growth
- PSTV N/A
- PRPH N/A
- EPS
- PSTV N/A
- PRPH N/A
- Revenue
- PSTV $5,317,000.00
- PRPH $5,588,000.00
- Revenue This Year
- PSTV $2.95
- PRPH $221.82
- Revenue Next Year
- PSTV $7.89
- PRPH N/A
- P/E Ratio
- PSTV N/A
- PRPH N/A
- Revenue Growth
- PSTV N/A
- PRPH N/A
- 52 Week Low
- PSTV $0.16
- PRPH $0.22
- 52 Week High
- PSTV $2.31
- PRPH $2.94
- Technical
- Relative Strength Index (RSI)
- PSTV 39.93
- PRPH 55.31
- Support Level
- PSTV $0.39
- PRPH $0.34
- Resistance Level
- PSTV $0.52
- PRPH $0.57
- Average True Range (ATR)
- PSTV 0.05
- PRPH 0.06
- MACD
- PSTV -0.01
- PRPH 0.01
- Stochastic Oscillator
- PSTV 10.00
- PRPH 40.37
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.